China · 
Who invested in EpimAB?
EpimAB's investors include 3E Bioventures and Oriza Seed Capital/ Decheng Capital.
China · Series A startup
Who invested in EpimAB
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2017, from 1 source
- Latest round
- Series A, $25MApr 2017
- Investors
- 2
The rounds
- Apr 2017
Everyone who backed them
Oriza Seed Capital/ Decheng Capitalno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about EpimAB
How much has EpimAB raised?
EpimAB has raised $25M across 1 round since 2017.
When did EpimAB last raise?
EpimAB's most recent round was a Series A of $25M in Apr 2017.
What was EpimAB's biggest round?
Its most recent round, $25M in Apr 2017, is also its largest on record.
Who backed EpimAB first?
EpimAB's first round on record, in Apr 2017, was backed by 3E Bioventures and Oriza Seed Capital/ Decheng Capital.
What stage is EpimAB at?
EpimAB's latest named round is a Series A, in Apr 2017.
Where is EpimAB based?
EpimAB is based in China.
Companies like EpimAB
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.